Found: 26
Select item for more details and to access through your institution.
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
- Published in:
- Journal of Neuroinflammation, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12974-024-03193-6
- By:
- Publication type:
- Article
Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis.
- Published in:
- Annals of Neurology, 2024, v. 96, n. 1, p. 1, doi. 10.1002/ana.26913
- By:
- Publication type:
- Article
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis.
- Published in:
- Journal of Neurology, 2024, v. 271, n. 5, p. 2149, doi. 10.1007/s00415-023-12179-y
- By:
- Publication type:
- Article
High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study.
- Published in:
- Annals of Neurology, 2024, v. 95, n. 4, p. 706, doi. 10.1002/ana.26870
- By:
- Publication type:
- Article
CSF levels of Chitinase3like1 correlate with early response to cladribine in multiple sclerosis.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1343892
- By:
- Publication type:
- Article
Prominent role of executive functioning on the Phonemic Fluency Test in people with multiple sclerosis.
- Published in:
- Journal of the International Neuropsychological Society, 2023, v. 29, n. 9, p. 902, doi. 10.1017/S1355617723000139
- By:
- Publication type:
- Article
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 7, p. 3315, doi. 10.1007/s00415-023-11768-1
- By:
- Publication type:
- Article
Cortical lesions at diagnosis predict long‐term cognitive impairment in multiple sclerosis: A 20‐year study.
- Published in:
- European Journal of Neurology, 2023, v. 30, n. 5, p. 1378, doi. 10.1111/ene.15697
- By:
- Publication type:
- Article
Slowing processing speed is associated with cognitive fatigue in newly diagnosed multiple sclerosis patients.
- Published in:
- Journal of the International Neuropsychological Society, 2023, v. 29, n. 3, p. 283, doi. 10.1017/S1355617722000157
- By:
- Publication type:
- Article
Intrathecal versus Peripheral Inflammatory Protein Profile in MS Patients at Diagnosis: A Comprehensive Investigation on Serum and CSF.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 4, p. 3768, doi. 10.3390/ijms24043768
- By:
- Publication type:
- Article
Immune Response after COVID-19 mRNA Vaccination in Multiple Sclerosis Patients Treated with DMTs.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3034, doi. 10.3390/biomedicines10123034
- By:
- Publication type:
- Article
Two years' effect of dimethyl fumarate on focal and diffuse gray matter pathology in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2090, doi. 10.1177/13524585221104014
- By:
- Publication type:
- Article
Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1937, doi. 10.1177/13524585221102158
- By:
- Publication type:
- Article
"Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, p. 1, doi. 10.1177/17562864221092124
- By:
- Publication type:
- Article
Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 5, p. 768, doi. 10.1177/13524585211032510
- By:
- Publication type:
- Article
Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 4, p. 550, doi. 10.1177/13524585211031786
- By:
- Publication type:
- Article
CSF TNF and osteopontin levels correlate with the response to dimethyl fumarate in early multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2022, v. 15, p. 1, doi. 10.1177/17562864221092124
- By:
- Publication type:
- Article
Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1712, doi. 10.3390/cells10071712
- By:
- Publication type:
- Article
Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 6, p. 1103, doi. 10.3390/diagnostics11061103
- By:
- Publication type:
- Article
The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 4, p. 686, doi. 10.3390/diagnostics11040686
- By:
- Publication type:
- Article
CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2021, v. 8, n. 3, p. 534, doi. 10.1002/acn3.51298
- By:
- Publication type:
- Article
Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients.
- Published in:
- Frontiers in Cellular Neuroscience, 2020, v. 14, p. N.PAG, doi. 10.3389/fncel.2020.569827
- By:
- Publication type:
- Article
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2019, v. 6, n. 11, p. 2150, doi. 10.1002/acn3.50893
- By:
- Publication type:
- Article
Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01666
- By:
- Publication type:
- Article